loading page

Molecular characterization and reclassification of a 1.18Mbp DMD duplication following positive carrier screening for Duchenne/Becker Muscular Dystrophy
  • +3
  • Cinthya Zepeda-Mendoza,
  • Jordan Bontrager,
  • Camille Fisher,
  • Amber McDonald,
  • Jaya George-Abraham,
Cinthya Zepeda-Mendoza
ARUP Laboratories

Corresponding Author:[email protected]

Author Profile
Jordan Bontrager
Mayo Clinic
Author Profile
Camille Fisher
Texas Oncology
Author Profile
Amber McDonald
Mayo Clinic
Author Profile
Jaya George-Abraham
Dell Children's Medical Center of Central Texas
Author Profile
Mayo Clinic
Author Profile


A 2-month-old male harboring a duplication of DMD exons 1-7 classified as pathogenic by an outside institution presented with mildly elevated CK levels; molecular breakpoint analysis by our laboratory reclassified the duplication as likely benign. To date, proband continues to develop normally with decreased CK levels, further supporting our reclassification.
09 Nov 2020Submitted to Clinical Case Reports
10 Nov 2020Submission Checks Completed
10 Nov 2020Assigned to Editor
18 Jan 2021Reviewer(s) Assigned
18 Jan 2021Review(s) Completed, Editorial Evaluation Pending
28 Mar 2021Editorial Decision: Revise Minor
21 Jun 20211st Revision Received
22 Jun 2021Submission Checks Completed
22 Jun 2021Assigned to Editor
22 Jun 2021Review(s) Completed, Editorial Evaluation Pending
20 Jul 2021Reviewer(s) Assigned
28 Jan 2022Editorial Decision: Accept